Acetazolamide modulates intracranial pressure directly by its action on the cerebrospinal fluid secretion apparatus.
Dagne BarbuskaiteEva K OernboJonathan H WardmanTrine L Toft-BertelsenEller ContiSøren N AndreassenNiklas J GerkauChristine R RoseNanna MacAulayPublished in: Fluids and barriers of the CNS (2022)
AZE lowers ICP directly via its ability to reduce the choroid plexus CSF secretion, irrespective of mode of drug administration.